C07C59/225

CO-CRYSTAL OF AFICAMTEN, AND PREPARATION METHOD THEREFOR AND USE THEREOF

The present disclosure relates to co-crystal of Aficamten and tartaric acid, and preparation methods thereof, pharmaceutical compositions containing the crystalline forms, and uses of the co-crystal for preparing cardiac myosin inhibitor and drugs for treating hypertrophic cardiomyopathy.

Salts of a compound and the crystalline forms thereof
12559472 · 2026-02-24 · ·

The present invention relates to the salts of a compound and the crystalline forms thereof. More specifically, the present invention belongs to the pharmaceutical field, and provides the pharmaceutically acceptable salts of the compound.